Wells Fargo’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $83.2K | Buy |
15,727
+1,310
| +9% | +$6.93K | ﹤0.01% | 4890 |
|
2025
Q1 | $117K | Buy |
14,417
+476
| +3% | +$3.88K | ﹤0.01% | 4578 |
|
2024
Q4 | $178K | Buy |
13,941
+4,070
| +41% | +$52.1K | ﹤0.01% | 4382 |
|
2024
Q3 | $106K | Sell |
9,871
-311
| -3% | -$3.33K | ﹤0.01% | 4596 |
|
2024
Q2 | $80.6K | Buy |
10,182
+660
| +7% | +$5.23K | ﹤0.01% | 4707 |
|
2024
Q1 | $153K | Buy |
9,522
+1,005
| +12% | +$16.1K | ﹤0.01% | 4272 |
|
2023
Q4 | $117K | Buy |
8,517
+1,484
| +21% | +$20.4K | ﹤0.01% | 4407 |
|
2023
Q3 | $103K | Sell |
7,033
-5,460
| -44% | -$79.8K | ﹤0.01% | 4431 |
|
2023
Q2 | $213K | Buy |
12,493
+10,270
| +462% | +$175K | ﹤0.01% | 4317 |
|
2023
Q1 | $31.1K | Sell |
2,223
-197
| -8% | -$2.75K | ﹤0.01% | 5128 |
|
2022
Q4 | $16K | Sell |
2,420
-746
| -24% | -$4.92K | ﹤0.01% | 5039 |
|
2022
Q3 | $17K | Buy |
3,166
+999
| +46% | +$5.36K | ﹤0.01% | 5159 |
|
2022
Q2 | $11K | Sell |
2,167
-5,614
| -72% | -$28.5K | ﹤0.01% | 5426 |
|
2022
Q1 | $66K | Sell |
7,781
-7,888
| -50% | -$66.9K | ﹤0.01% | 5199 |
|
2021
Q4 | $188K | Buy |
15,669
+14,288
| +1,035% | +$171K | ﹤0.01% | 4931 |
|
2021
Q3 | $24K | Hold |
1,381
| – | – | ﹤0.01% | 5592 |
|
2021
Q2 | $28K | Hold |
1,381
| – | – | ﹤0.01% | 5453 |
|
2021
Q1 | $27K | Sell |
1,381
-10,222
| -88% | -$200K | ﹤0.01% | 5707 |
|
2020
Q4 | $215K | Buy |
11,603
+10,971
| +1,736% | +$203K | ﹤0.01% | 4916 |
|
2020
Q3 | $16K | Sell |
632
-2,130
| -77% | -$53.9K | ﹤0.01% | 5507 |
|
2020
Q2 | $84K | Buy |
2,762
+2,257
| +447% | +$68.6K | ﹤0.01% | 5083 |
|
2020
Q1 | $16K | Buy |
505
+305
| +153% | +$9.66K | ﹤0.01% | 5379 |
|
2019
Q4 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 5584 |
|